Evidence map›Paper›PMID 11574475›Full record

ArticleThe EMBO journal2001

A completely foreign receptor can mediate an interferon-gamma-like response.

B Strobl, V Arulampalam, H Is'harc, S J Newman, J F Schlaak, D Watling, A P Costa-Pereira, F Schaper, I Behrmann, K C Sheehan and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Signaling by STATs.Arthritis research & therapy · 2004
    Review
  4. Review
  5. Article
  6. Article
  7. Mutational switch of an IL-6 response to an interferon-gamma-like response.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 2 countries.

B StroblImperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
V Arulampalam
H Is'harc
S J Newman
J F Schlaak
D Watling
A P Costa-Pereira
F Schaper
I Behrmann
K C Sheehan
R D Schreiber
F Horn
P C Heinrich
I M Kerr
The Honourable Society of Lincoln's Inn · GB

Funding

THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITINGR01CA043059 · NCI · WASHINGTON UNIVERSITY · PI SCHREIBER, ROBERT DAVID · 1986 to 2014
$3.8M
MOLECULAR REGULATION OF MACROPHAGE CYTOCIDAL ACTIVITYR37CA043059 · NCI · WASHINGTON UNIVERSITY · PI SCHREIBER, ROBERT DAVID · 1995 to 2002
$1.2M
NCI NIH HHS CA 43059NCI NIH HHS R01 CA043059NCI NIH HHS R37 CA043059
6 · The paper itself

Abstract

A tripartite receptor comprising the external region of the erythropoietin (Epo) receptor, the transmembrane and JAK-binding domains of the gp130 subunit of the interleukin-6 (IL-6) receptor, and a seven amino acid STAT1 recruitment motif (Y440) from the interferon (IFN)-gamma receptor, efficiently mediates an IFN-gamma-like response. An analogous completely foreign chimeric receptor in which the Y440 motif is replaced with the Y905 motif from gp130 also mediates an IFN-gamma-like response, but less efficiently. The IFNGR1 signal-transducing subunit of the IFN-gamma receptor is tyrosine phosphorylated through the chimeric receptors and the endogenous IL-6 and OSM receptors. Cross phosphorylation of IFNGR1 is not, however, required for the IFN-gamma-like response through the chimeric receptors, nor does it mediate an IFN-gamma-like response to IL-6 or OSM. The data argue strongly for modular JAK/STAT signalling and against any rigid structural organization for the "pathways" involved. They emphasize the likely high degree of overlap between the signals generated from disparate JAK-receptor complexes and show that relatively minor changes in such complexes can profoundly affect the response.

Indexed as

Nuclear ProteinsDNA-Binding ProteinsGene Expression RegulationHistocompatibility Antigens Class IIHumansInterferon-gammaInterferon gamma ReceptorReceptor, Interferon alpha-betaReceptors, ErythropoietinReceptors, ImmunologicReceptors, InterferonReceptors, Interleukin-6Recombinant Fusion ProteinsSignal TransductionSTAT1 Transcription FactorTrans-ActivatorsDNA-Binding ProteinsHistocompatibility Antigens Class IIInterferon-gammaInterferon gamma ReceptorMHC class II transactivator proteinNuclear ProteinsReceptor, Interferon alpha-betaReceptors, ErythropoietinReceptors, ImmunologicReceptors, InterferonReceptors, Interleukin-6Recombinant Fusion ProteinsSTAT1 protein, humanSTAT1 Transcription FactorTrans-Activators

Identifiers

PMID11574475
PMCPMC125275
OpenAlexW2113605746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.